Aparna Shetty

Scientific Communications And Content Lead, Gene Therapies at Astellas Gene Therapies

Aparna Shetty has a diverse range of work experience, primarily in the field of scientific communications and publications. Aparna is currently working at Astellas Gene Therapies as the Scientific Communications and Content Lead for Gene Therapies. Prior to this role, they held positions at Natera as a Senior Medical Writer in Science Communications and Publications, and at Prime Global as a Senior Medical Writer and Medical Writer. Aparna also has experience as a Guest Lecturer for a summer program at The Branson School. Additionally, Aparna has worked as a Medical Associate at The Scienomics Group, where they were responsible for conveying complex scientific concepts to diverse audiences and providing scientific support for promotional and un-branded content. In the past, they also worked as a Coordinator for a high school summer internship program at the UCSF neurology department, a Research Mentor at the Branson Summer STEM Institute, and a Scientist Mentor for high school students at the UCSF Center for Educational Partnerships, BayBio. Aparna's work experience demonstrates their expertise in scientific communications, publications, and education.

Aparna Shetty attended Vidya Niketan School, Hebbal, Bangalore from 1982 to 1996, where they completed their high school education. Aparna then went on to study at Bangalore University from 1996 to 2000, earning a Pre University and Bachelor's degree in Microbiology. From 2000 to 2002, they pursued their Masters in Biochemistry at Maharajo Sayaji Rao University (MSU), Baroda. Aparna continued their education at the University of Hamburg, where they obtained a Doctor of Philosophy (Ph.D.) in Neuroscience from 2003 to 2008. Finally, they attended the University of California, San Francisco from 2010 to 2014 as a Postdoctoral Fellow, specializing in the field of Neurology/Immunology.

Links

Previous companies

Natera logo
Prime Global logo
The Branson School logo

Timeline

  • Scientific Communications And Content Lead, Gene Therapies

    May, 2023 - present

  • Scientific Communications Interim Lead Gene Therapies

    June, 2022

  • Director Scientific Publications TA Lead

    October, 2021

  • Associate Director Scientific Publications

    July, 2020

View in org chart